All‐cause mortality · heart failure associated with central sleep apnoea
It is very uncertain whether PAP therapy changes all‐cause mortality compared with usual care (very low certainty).
1 finding from 1 review
Cardiac disease‐ related mortality · heart failure associated with central sleep apnoea
PAP therapy showed no clear difference in cardiac‐related mortality compared with usual care (moderate certainty).
1 finding from 1 review
Patient readmissions · heart failure associated with central sleep apnoea
PAP therapy showed no clear difference in all‐cause rehospitalisation compared with usual care (low certainty).
1 finding from 1 review
Cardiac‐related rehospitalisation · heart failure associated with central sleep apnoea
PAP therapy showed no clear difference in cardiac‐related rehospitalisation compared with usual care (low certainty).
1 finding from 1 review
QoL · heart failure associated with central sleep apnoea
2 findings from 1 review
Adverse events · heart failure associated with central sleep apnoea
1 finding from 1 review
Health‐related quality of life · DCM (non‐ischaemic)
1 finding from 1 review
Performance status – functional class (NYHA) · DCM (non‐ischaemic)
1 finding from 1 review
Functional capacityAssessed: 6MWT · DCM (non‐ischaemic)
1 finding from 1 review
MACE · DCM (non‐ischaemic)
1 finding from 1 review
All‐cause mortality · DCM (non‐ischaemic)
It is very uncertain whether stem cell therapy (any type) changes all‐cause mortality compared with peripheral therapy with granulocyte colony‐stimulating factor (very low certainty).
1 finding from 1 review
Procedural complications · DCM (non‐ischaemic)
1 finding from 1 review
Death (all‐causes) · Post‐menopausal women without prior cardiovascular disease
Hormone therapy showed no clear difference in death (all‐causes) compared with placebo (high certainty).
1 finding from 1 review
Pulmonary embolism · Post‐menopausal women with pre‐exisiting cardiovascular disease
Hormone therapy showed no clear difference in pulmonary embolism compared with placebo (moderate certainty).
1 finding from 1 review
All cardiovascular death · Post‐menopausal women without prior cardiovascular disease
Hormone therapy showed no clear difference in death (cardiovascular causes) compared with placebo (high certainty).
1 finding from 1 review
Stroke · Post‐menopausal women without prior cardiovascular disease
Hormone therapy leads to higher stroke compared with placebo (high certainty).
1 finding from 1 review
Venous thromboembolism · Post‐menopausal women without prior cardiovascular disease
Hormone therapy probably leads to higher venous thromboembolism compared with placebo (moderate certainty).
1 finding from 1 review
Pulmonary embolism · Post‐menopausal women without prior cardiovascular disease
1 finding from 1 review
Death (all‐causes) · Post‐menopausal women with pre‐exisiting cardiovascular disease
Hormone therapy showed no clear difference in death (all‐causes) compared with placebo (high certainty).
1 finding from 1 review
All cardiovascular death · Post‐menopausal women with pre‐exisiting cardiovascular disease
Hormone therapy showed no clear difference in death (cardiovascular causes) compared with placebo (high certainty).
1 finding from 1 review